These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Aggregation-Induced Emission Photosensitizer-Engineered Anticancer Nanomedicine for Synergistic Chemo/Chemodynamic/Photodynamic Therapy. Yu B; Liu M; Jiang L; Xu C; Hu H; Huang T; Xu D; Wang N; Li Q; Tang BZ; Huang X; Zhang W Adv Healthc Mater; 2024 Apr; 13(11):e2303643. PubMed ID: 38115727 [TBL] [Abstract][Full Text] [Related]
24. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma. Banelli B; Carra E; Barbieri F; Würth R; Parodi F; Pattarozzi A; Carosio R; Forlani A; Allemanni G; Marubbi D; Florio T; Daga A; Romani M Cell Cycle; 2015; 14(21):3418-29. PubMed ID: 26566863 [TBL] [Abstract][Full Text] [Related]
25. Dual-selective photodynamic therapy with a mitochondria-targeted photosensitizer and fiber optic cannula for malignant brain tumors. Kang JH; Ko YT Biomater Sci; 2019 Jul; 7(7):2812-2825. PubMed ID: 31066391 [TBL] [Abstract][Full Text] [Related]
26. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists. Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057 [TBL] [Abstract][Full Text] [Related]
27. Glutathione peroxidase 1 activity dictates the sensitivity of glioblastoma cells to oxidative stress. Dokic I; Hartmann C; Herold-Mende C; Régnier-Vigouroux A Glia; 2012 Nov; 60(11):1785-800. PubMed ID: 22951908 [TBL] [Abstract][Full Text] [Related]
28. The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma. Ozyerli-Goknar E; Sur-Erdem I; Seker F; Cingöz A; Kayabolen A; Kahya-Yesil Z; Uyulur F; Gezen M; Tolay N; Erman B; Gönen M; Dunford J; Oppermann U; Bagci-Onder T Cell Death Dis; 2019 Nov; 10(12):894. PubMed ID: 31772153 [TBL] [Abstract][Full Text] [Related]
29. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma. Chen Z; Wei X; Shen L; Zhu H; Zheng X Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207 [TBL] [Abstract][Full Text] [Related]
30. Antioxidant network-based signatures cluster glioblastoma into distinct redox-resistant phenotypes. Yang Y; More S; De Smet F; De Vleeschouwer S; Agostinis P Front Immunol; 2024; 15():1342977. PubMed ID: 38698847 [TBL] [Abstract][Full Text] [Related]
31. Exploring the Functional Roles of Telomere Maintenance 2 in the Tumorigenesis of Glioblastoma Multiforme and Drug Responsiveness to Temozolomide. Feng SW; Wu ZS; Chiu YL; Huang SM Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298208 [TBL] [Abstract][Full Text] [Related]
32. Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status. Chong DQ; Toh XY; Ho IA; Sia KC; Newman JP; Yulyana Y; Ng WH; Lai SH; Ho MM; Dinesh N; Tham CK; Lam PY BMC Cancer; 2015 Apr; 15():255. PubMed ID: 25886314 [TBL] [Abstract][Full Text] [Related]
33. NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation. Su IC; Su YK; Setiawan SA; Yadav VK; Fong IH; Yeh CT; Lin CM; Liu HW Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175412 [TBL] [Abstract][Full Text] [Related]
35. Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation. Liu YJ; Ma YC; Zhang WJ; Yang ZZ; Liang DS; Wu ZF; Qi XR Oncotarget; 2017 Jun; 8(26):42495-42509. PubMed ID: 28477008 [TBL] [Abstract][Full Text] [Related]
36. Targeting the ABC transporter ABCB5 sensitizes glioblastoma to temozolomide-induced apoptosis through a cell-cycle checkpoint regulation mechanism. Lee CAA; Banerjee P; Wilson BJ; Wu S; Guo Q; Berg G; Karpova S; Mishra A; Lian JW; Tran J; Emmerich M; Murphy GF; Frank MH; Frank NY J Biol Chem; 2020 May; 295(22):7774-7788. PubMed ID: 32317280 [TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of the effects of a sphingosine kinase inhibitor to temozolomide and radiation treatment on glioblastoma cell lines. Oancea-Castillo LR; Klein C; Abdollahi A; Weber KJ; Régnier-Vigouroux A; Dokic I Cancer Biol Ther; 2017 Jun; 18(6):400-406. PubMed ID: 28494176 [TBL] [Abstract][Full Text] [Related]